Concepedia

Anne M. Traynor

AM

Statistics

Publications

62

Citations

3.7K

H-Index

36

Active since

2003

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

University of Wisconsin–Madison

National Cancer Institute

Regional Cancer Center

The University of Texas Southwestern Medical Center

Anne M. Traynor is an author at University of Wisconsin Carbone Cancer Center specializing in medicine, oncology, and pharmacology.

ORCID

Publications per year

2003–2024

62

Publications

62

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Keith C. Bible, Vera J. Suman, Julian R. Molina et al. · The Lancet Oncology · 2010 · 416 citations · Full text

, , +8

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

Keith C. Bible, Vera J. Suman, Michael E. Menefee et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 176 citations · Full text

, , +15

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

Heather A. Wakelee, Suzanne E. Dahlberg, Steven M. Keller et al. · The Lancet Oncology · 2017 · 172 citations · Full text

, , +14

Dose-Limiting Toxicity After Hypofractionated Dose-Escalated Radiotherapy in Non–Small-Cell Lung Cancer

Donald M. Cannon, Minesh P. Mehta, Jarrod B. Adkison et al. · Journal of Clinical Oncology · 2013 · 161 citations · Full text

, , +15

Vorinostat (NSC# 701852) in Patients with Relapsed Non-small Cell Lung Cancer: A Wisconsin Oncology Network Phase II Study

Anne M. Traynor, Sarita Dubey, Jens C. Eickhoff et al. · Journal of Thoracic Oncology · 2009 · 139 citations · Full text

, , +9

1–5 of 62